Heart Attack

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction

MULHOUSE, France, and SUNNYVALE, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CellProthera, a private company specializing in cell-based therapies for…

5 months ago

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset Powered by this AI, the…

5 months ago

Erie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension Management

Collaboration Doubles Blood Pressure Control for High-Risk Patients in 12 Weeks BUFFALO, N.Y., June 25, 2024 /PRNewswire/ -- Brook Health,…

5 months ago

Single-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular Vesicles

LOS ANGELES, June 18, 2024 /PRNewswire/ -- Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced a new publication…

5 months ago

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Gap in non-oral prescriptions relative to AHS guidelines represents an opportunity to increase awareness of Tonix’s two FDA-approved non-oral treatments…

5 months ago

MedsEngine and NI Medical Announce Improved Cardiovascular Outcomes Utilizing NICaS Hemodynamic Measurements with MedsEngine Clinical Decision Support Software for Hypertension

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine and NI Medical are pleased to announce they will be presenting a comprehensive analysis on their management…

5 months ago

Buck Institute and Sens.ai Collaborate to Study Brain Aging

New Longevity Tech Collaboration Will Research and Develop First-Ever Biological Clock for the Brain WHISTLER, BC, June 6, 2024 /PRNewswire/…

6 months ago

Prevencio Selected for Prestigious MedTech Innovator 2024 Accelerator Cohort

KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc., a leader in AI-powered blood tests for cardiovascular diagnostics, has been selected to join the 2024…

6 months ago

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”),…

6 months ago